Mangumpit, Perry An R.
HRN: 15-57-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2024
CEFUROXIME 1.5GM (VIAL)
01/21/2024
01/24/2024
IV
1.5 Grams
Q8hrs
CAP-MR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes